Hindoostan Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 1, 2025, 5:54 pm

Quick Insight

Hindoostan Mills Ltd, operating in the textiles sector, presents a compelling yet complex investment case. With a market capitalization of ₹30.7 crore and a current share price of ₹185, the company shows a P/BV ratio of 0.73x, indicating it may be undervalued relative to its book value. However, the company's financials reveal challenges, including a negative net profit margin of 11% and an operating profit margin (OPM) of -47.64%. Despite these hurdles, Hindoostan boasts a strong return on equity (ROE) of 24.1% and return on capital employed (ROCE) of 22.9%, suggesting efficient utilization of shareholder funds. The low borrowings of ₹1 crore and a comfortable cash conversion cycle (CCC) of 28 days further enhance its stability. Given the current metrics, potential investors should weigh the high promoter holding of 60.47% against the company's operational struggles, making this a speculative opportunity that requires careful consideration of its turnaround potential.

Competitors of Hindoostan Mills Ltd

All Competitor Stocks of Hindoostan Mills Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:43 am

Below is a detailed analysis of the quarterly data for Hindoostan Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 4.24 Cr.. The value appears to be declining and may need further review. It has decreased from 5.59 Cr. (Dec 2024) to 4.24 Cr., marking a decrease of 1.35 Cr..
• For Expenses, as of Mar 2025, the value is 6.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.60 Cr. (Dec 2024) to 6.26 Cr., marking a decrease of 1.34 Cr..
• For Operating Profit, as of Mar 2025, the value is -2.02 Cr.. The value appears to be declining and may need further review. It has decreased from -2.01 Cr. (Dec 2024) to -2.02 Cr., marking a decrease of 0.01 Cr..
• For OPM %, as of Mar 2025, the value is -47.64%. The value appears to be declining and may need further review. It has decreased from -35.96% (Dec 2024) to -47.64%, marking a decrease of 11.68%.
• For Other Income, as of Mar 2025, the value is 0.54 Cr.. The value appears strong and on an upward trend. It has increased from 0.53 Cr. (Dec 2024) to 0.54 Cr., marking an increase of 0.01 Cr..
• For Interest, as of Mar 2025, the value is 0.04 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.04 Cr..
• For Depreciation, as of Mar 2025, the value is 0.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.44 Cr. (Dec 2024) to 0.64 Cr., marking an increase of 0.20 Cr..
• For Profit before tax, as of Mar 2025, the value is -2.16 Cr.. The value appears to be declining and may need further review. It has decreased from -1.96 Cr. (Dec 2024) to -2.16 Cr., marking a decrease of 0.20 Cr..
• For Tax %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
• For Net Profit, as of Mar 2025, the value is -2.16 Cr.. The value appears to be declining and may need further review. It has decreased from -1.96 Cr. (Dec 2024) to -2.16 Cr., marking a decrease of 0.20 Cr..
• For EPS in Rs, as of Mar 2025, the value is -12.98. The value appears to be declining and may need further review. It has decreased from -11.78 (Dec 2024) to -12.98, marking a decrease of 1.20.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:13 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:06 pm

Below is a detailed analysis of the balance sheet data for Hindoostan Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Reserves, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Mar 2024) to 37.00 Cr., marking a decrease of 11.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing). It has decreased from 23.00 Cr. (Mar 2024) to 15.00 Cr., marking a decrease of 8.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 55.00 Cr.. The value appears to be improving (decreasing). It has decreased from 75.00 Cr. (Mar 2024) to 55.00 Cr., marking a decrease of 20.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 23.00 Cr..
• For Total Assets, as of Mar 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2024) to 55.00 Cr., marking a decrease of 20.00 Cr..

Notably, the Reserves (37.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hindoostan Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -64.72. This value is below the healthy minimum of 5. It has decreased from 7.62 (Mar 24) to -64.72, marking a decrease of 72.34.
• For Diluted EPS (Rs.), as of Mar 25, the value is -64.72. This value is below the healthy minimum of 5. It has decreased from 7.62 (Mar 24) to -64.72, marking a decrease of 72.34.
• For Cash EPS (Rs.), as of Mar 25, the value is -52.90. This value is below the healthy minimum of 3. It has decreased from 20.58 (Mar 24) to -52.90, marking a decrease of 73.48.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 235.24. It has decreased from 301.17 (Mar 24) to 235.24, marking a decrease of 65.93.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 235.24. It has decreased from 301.17 (Mar 24) to 235.24, marking a decrease of 65.93.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 199.17. It has decreased from 530.27 (Mar 24) to 199.17, marking a decrease of 331.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -51.47. This value is below the healthy minimum of 2. It has decreased from 23.12 (Mar 24) to -51.47, marking a decrease of 74.59.
• For PBIT / Share (Rs.), as of Mar 25, the value is -63.30. This value is below the healthy minimum of 0. It has decreased from 10.15 (Mar 24) to -63.30, marking a decrease of 73.45.
• For PBT / Share (Rs.), as of Mar 25, the value is -64.72. This value is below the healthy minimum of 0. It has decreased from 7.62 (Mar 24) to -64.72, marking a decrease of 72.34.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -64.72. This value is below the healthy minimum of 2. It has decreased from 7.62 (Mar 24) to -64.72, marking a decrease of 72.34.
• For PBDIT Margin (%), as of Mar 25, the value is -25.84. This value is below the healthy minimum of 10. It has decreased from 4.35 (Mar 24) to -25.84, marking a decrease of 30.19.
• For PBIT Margin (%), as of Mar 25, the value is -31.78. This value is below the healthy minimum of 10. It has decreased from 1.91 (Mar 24) to -31.78, marking a decrease of 33.69.
• For PBT Margin (%), as of Mar 25, the value is -32.49. This value is below the healthy minimum of 10. It has decreased from 1.43 (Mar 24) to -32.49, marking a decrease of 33.92.
• For Net Profit Margin (%), as of Mar 25, the value is -32.49. This value is below the healthy minimum of 5. It has decreased from 1.43 (Mar 24) to -32.49, marking a decrease of 33.92.
• For Return on Networth / Equity (%), as of Mar 25, the value is -27.51. This value is below the healthy minimum of 15. It has decreased from 2.52 (Mar 24) to -27.51, marking a decrease of 30.03.
• For Return on Capital Employeed (%), as of Mar 25, the value is -23.84. This value is below the healthy minimum of 10. It has decreased from 2.83 (Mar 24) to -23.84, marking a decrease of 26.67.
• For Return On Assets (%), as of Mar 25, the value is -19.48. This value is below the healthy minimum of 5. It has decreased from 1.68 (Mar 24) to -19.48, marking a decrease of 21.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has decreased from 1.17 (Mar 24) to 0.50, marking a decrease of 0.67.
• For Current Ratio (X), as of Mar 25, the value is 2.06. This value is within the healthy range. It has decreased from 2.64 (Mar 24) to 2.06, marking a decrease of 0.58.
• For Quick Ratio (X), as of Mar 25, the value is 1.77. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 1.77, marking an increase of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 4. It has decreased from 3.23 (Mar 24) to 1.10, marking a decrease of 2.13.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -36.10. This value is below the healthy minimum of 3. It has decreased from 9.11 (Mar 24) to -36.10, marking a decrease of 45.21.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -44.40. This value is below the healthy minimum of 3. It has decreased from 4.00 (Mar 24) to -44.40, marking a decrease of 48.40.
• For Enterprise Value (Cr.), as of Mar 25, the value is 15.86. It has decreased from 30.80 (Mar 24) to 15.86, marking a decrease of 14.94.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.47, marking an increase of 0.13.
• For EV / EBITDA (X), as of Mar 25, the value is -1.85. This value is below the healthy minimum of 5. It has decreased from 8.01 (Mar 24) to -1.85, marking a decrease of 9.86.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.46 (Mar 24) to 0.86, marking an increase of 0.40.
• For Price / BV (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.73, marking a decrease of 0.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.46 (Mar 24) to 0.86, marking an increase of 0.40.
• For EarningsYield, as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to -0.37, marking a decrease of 0.40.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness